Wilmington Savings Fund Society’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24K Hold
1,000
﹤0.01% 1309
2026
Q1
$2.47K Hold
1,000
﹤0.01% 1334
2025
Q4
$2.05K Hold
1,000
﹤0.01% 1314
2025
Q3
$3.47K Hold
1,000
﹤0.01% 1263
2025
Q2
$2.2K Hold
1,000
﹤0.01% 1892
2025
Q1
$1.16K Hold
1,000
﹤0.01% 1979
2024
Q4
$1.27K Hold
1,000
﹤0.01% 1985
2024
Q3
$3.41K Buy
+1,000
New +$4.35K ﹤0.01% 1837

Other funds holding EDIT

Wilmington Savings Fund Society's EDIT Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Editas Medicine (EDIT) position steady in Q2 2026 at 1,000 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Wilmington Savings Fund Society first reported a position in EDIT in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.47K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Wilmington Savings Fund Society held 1,000 shares of Editas Medicine worth $3.24K as of Q2 2026.
  • Wilmington Savings Fund Society left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1309 holding.
  • Wilmington Savings Fund Society first reported a position in Editas Medicine in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's Editas Medicine position peaked at $3.47K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.